NCT05101551
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05101551
Title Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy (PARPAML)
Acronym PARPAML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Norman J. Lacayo
Indications
Therapies
Age Groups: adult | child
Covered Countries USA

Facility Status City State Zip Country Details
Phoenix Children's Hospital RECRUITING Phoenix Arizona 85016 United States Details
Arkansas Children's Hospital RECRUITING Little Rock Arkansas 72202 United States Details
City of Hope RECRUITING Duarte California 91010 United States Details
Stanford University RECRUITING Stanford California 94305 United States Details
Cincinnati Children's Hospital RECRUITING Cincinnati Ohio 45229 United States Details
Pennsylvania State University Hershey Medical Center RECRUITING Hershey Pennsylvania 17033-0850 United States Details
St. Jude Children's Research Hospital RECRUITING Memphis Tennessee 38105 United States Details
University of Utah RECRUITING Salt Lake City Utah 84108 United States Details
University of Wisconsin Carbone Cancer Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field